Bioethics News

A Year After Approval, Gene-Therapy Cure Gets Its First Customer

GlaxoSmithKline says it has treated a child with Strimvelis, its gene therapy for immune deficiency

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.